Health Care · Pharmaceutical Preparations · Nasdaq · CIK 890821 · FYE Dec 31 · Prices AT CLOSE 2026-07-28 (USD) — end-of-day, never a live or intraday quote
Last $1.33Day −0.75%Mkt cap $5M1Y −91.2%Off 52W high −92.5%Vol (1Y) 177.5%
Daily closing price, split-adjusted to the current basis; 2.9y shown of 1,223 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.5% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)−0.00% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-15 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$8.2M |
| ROE−304.0% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−63.4% |
| 1Y−91.2% |
| 3Y−100.0% |
| 5Y−100.0% |
| Since incept. (ann.)−90.8% |
Total return through 2026-07-28 · series begins 2021-02-22. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)177.5% |
| Ann. volatility (3Y)157.0% |
| Sharpe (1Y)−0.64 |
| Sharpe (3Y)−0.82 |
| Max drawdown (1Y)−92.7% |
| Max drawdown (3Y)−100.0% |
| Beta (3Y vs SPY)2.17 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 32,149 | $62,368 | 0.87% | new |
| AdvisorShares Investments LLC | 16,974 | $32,930 | 0.46% | +0.0% |
| UBS Group AG | 3,612 | $7,008 | 0.10% | +24.8% |
| Tower Research Capital LLC (TRC) | 1,103 | $2,140 | 0.03% | −42.5% |
| JONES FINANCIAL COMPANIES LLLP | 1,000 | $1,880 | 0.03% | new |
| SBI Securities Co., Ltd. | 83 | $161 | 0.00% | +69.4% |
| BlackRock, Inc. | 51 | $99 | 0.00% | +0.0% |
| WELLS FARGO & COMPANY/MN | 1 | $2 | 0.00% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | −$1.08 | — | — | — |
| 2025-09-30 | 2025-11-14 | — | — | — | — |
| 2025-06-30 | 2025-08-14 | — | — | — | — |
| 2025-03-31 | 2025-05-14 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-15 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
